OSAKA, Japan & ATLANTA--(BUSINESS WIRE)--
Shionogi & Co., Ltd. (“Shionogi”) and Sciele Pharma, Inc. (“Sciele”) (NASDAQ: SCRX) announced today that the waiting period under the Hart Scott Rodino Antitrust Improvements Act of 1976 with respect to Shionogi's indirect wholly owned subsidiary’s cash tender offer for all outstanding shares of common stock of Sciele at a price of $31.00 per share expired at 11:59 P.M., New York City time, on September 18, 2008.
